Company Profile
Ortin Global provides the manufacture and trading of pharmaceuticals, drugs, and intermediates in India. The company offers various pharmaceutical formulations of tablets, capsules, syrups, and dry powders
Formulations, such as anti-diabetics, anti-allergics, anti-anginal and cardiovascular, sedatives and tranquilisers, anti-helmenthetics, analgesics and antipyretics, anti-biotics-quinolones, anti-biotic-pencillins, antifungal, cephalosporins, and macrolides.
Its formulations also include chemo therapeutics, antacids and anti-ulcerants, anti-spasmodics, calcium and iron preparations, anti-arthritic drugs, protein supplements, enzymes, and vitamins Psychiatry, appetizer, gynaec, and anti-retroviral products, as well as active pharmaceutical ingredient (API) intermediates
Including anti-retroviral, anti-diabetics, analgesics and antipyretics, anti-biotics, antifungal, antacids and anti-ulcerants, and anti-malarials manufactures fine chemicals, and grignard and alkali metal products.
It also provides services in the areas of process development, process and product characterization, analytical R&D, and assay development. Its portfolio also includes R&D services for new formulation brands, and diagnostic services comprising development of rapid flow kits, assays, and reagents.
Additionally, it undertakes long-term contracts for manufacturing intermediates and developing new APIs. Its portfolio also includes operates as a merchant exporter of pharmaceutical finished formulations, and engages in real estate. Incorporated in 1986 and headquartered in Hyderabad, India, Ortin Global was formerly known as Ortin Laboratories Limited before rebranding in June 2024.